Literature DB >> 16214653

Bone and joint disease in sickle cell disease.

Christine Aguilar1, Elliott Vichinsky, Lynne Neumayr.   

Abstract

Bone and joint disorders are the most common cause of chronic pain in patients who have sickle cell disease. The femoral head is the most common area of bone destruction in sickle cell patients, although other disease-related problems include avascular necrosis of the humeral head, changes in the thoracic and lumbar spine, infection with encapsulated organisms (Salmonella and Staphylococcus aureus are the most common), bone marrow disturbances, and dental effects. Complications can occur at any location: epiphyseal, metaphyseal, or diaphyseal. The location and the extensiveness of the problems determine the pain and structural damage. The hip joint is particularly vulnerable in sickle cell disease. This article highlights aspects of sickle cell disease that affect healthy bone and joint function and discusses treatment options.

Entities:  

Mesh:

Year:  2005        PMID: 16214653     DOI: 10.1016/j.hoc.2005.07.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  17 in total

1.  The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A.

Authors:  G Castañeda-Corral; J M Jimenez-Andrade; A P Bloom; R N Taylor; W G Mantyh; M J Kaczmarska; J R Ghilardi; P W Mantyh
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  Imaging review of sickle cell disease for the emergency radiologist.

Authors:  Shenise N Gilyard; Scott L Hamlin; Jamlik-Omari Johnson; Keith D Herr
Journal:  Emerg Radiol       Date:  2020-07-31

3.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

Review 4.  Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.

Authors:  Oyebimpe O Adesina; Lynne D Neumayr
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Sickle cell disease: an opportunity for palliative care across the life span.

Authors:  Diana J Wilkie; Bonnye Johnson; A Kyle Mack; Richard Labotka; Robert E Molokie
Journal:  Nurs Clin North Am       Date:  2010-09       Impact factor: 1.208

6.  Microarchitectural and mechanical characterization of the sickle bone.

Authors:  Mykel Green; Idowu Akinsami; Angela Lin; Shereka Banton; Samit Ghosh; Binbin Chen; Manu Platt; Ifeyinwa Osunkwo; Solomon Ofori-Acquah; Robert Guldberg; Gilda Barabino
Journal:  J Mech Behav Biomed Mater       Date:  2015-04-24

7.  Sickle cell bone disease and response to intravenous bisphosphonates in children.

Authors:  C Grimbly; P Diaz Escagedo; J L Jaremko; A Bruce; N Alos; M E Robinson; V N Konji; M Page; M Scharke; E Simpson; Y D Pastore; R Girgis; R T Alexander; L M Ward
Journal:  Osteoporos Int       Date:  2022-07-29       Impact factor: 5.071

8.  Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.

Authors:  Ellen B Fung; Paul R Harmatz; Meredith Milet; Thomas D Coates; Alexis A Thompson; Mark Ranalli; Robert Mignaca; Charles Scher; Patricia Giardina; Shanda Robertson; Lynne Neumayr; Elliott P Vichinsky
Journal:  Bone       Date:  2008-03-15       Impact factor: 4.398

9.  Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

Authors:  Natasha M Rogers; Mingyi Yao; John Sembrat; M Patricia George; Heather Knupp; Mark Ross; Maryam Sharifi-Sanjani; Jadranka Milosevic; Claudette St Croix; Revathi Rajkumar; Maria G Frid; Kendall S Hunter; Luciano Mazzaro; Enrico M Novelli; Kurt R Stenmark; Mark T Gladwin; Ferhaan Ahmad; Hunter C Champion; Jeffrey S Isenberg
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

10.  Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a cross-sectional study.

Authors:  Gildasio Daltro; Bruno Adelmo Franco; Thiago Batista Faleiro; Davi Araujo Veiga Rosário; Paula Braga Daltro; Vitor Fortuna
Journal:  Int Orthop       Date:  2018-03-26       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.